Survival Analysis

"Survival Analysis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A class of statistical procedures for estimating the survival function (function of time, starting with a population 100% well at a given time and providing the percentage of the population still well at later times). The survival analysis is then used for making inferences about the effects of treatments, prognostic factors, exposures, and other covariates on the function.

Descriptor ID	D016019
MeSH Number(s)	E05.318.740.998 N05.715.360.750.795 N06.850.520.830.998
Concept/Terms	Survival Analysis Survival Analysis Analysis, Survival Analyses, Survival Survival Analyses

Below are MeSH descriptors whose meaning is more general than "Survival Analysis".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Investigative Techniques [E05]
Epidemiologic Methods [E05.318]
Statistics as Topic [E05.318.740]
Survival Analysis [E05.318.740.998]
Health Care [N]
Health Care Quality, Access, and Evaluation [N05]
Quality of Health Care [N05.715]
Health Care Evaluation Mechanisms [N05.715.360]
Statistics as Topic [N05.715.360.750]
Survival Analysis [N05.715.360.750.795]
Environment and Public Health [N06]
Public Health [N06.850]
Epidemiologic Methods [N06.850.520]
Statistics as Topic [N06.850.520.830]
Survival Analysis [N06.850.520.830.998]

Below are MeSH descriptors whose meaning is more specific than "Survival Analysis".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Survival Analysis" by people in this website by year, and whether "Survival Analysis" was a major or minor topic of these publications.

Bar chart showing 261 publications over 30 distinct years, with a maximum of 23 publications in 2013

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1994	0	1	1
1995	0	2	2
1996	0	1	1
1998	0	1	1
1999	0	2	2
2000	0	1	1
2001	0	1	1
2002	0	5	5
2003	0	6	6
2004	0	10	10
2005	0	16	16
2006	0	5	5
2007	0	10	10
2008	0	16	16
2009	0	17	17
2010	0	9	9
2011	0	18	18
2012	0	13	13
2013	0	23	23
2014	1	12	13
2015	1	15	16
2016	1	14	15
2017	1	12	13
2018	0	17	17
2019	0	10	10
2020	0	8	8
2021	0	7	7
2022	0	2	2
2023	0	2	2
2024	0	1	1

Below are the most recent publications written about "Survival Analysis" by people in Profiles.

Kim J, Macharia PM, McCormack V, Foerster M, Galukande M, Joffe M, Cubasch H, Zietsman A, Anele A, Offiah S, Parham G, Pinder LF, Anderson BO, Sch?z J, Dos Santos-Silva I, Togawa K. Geospatial disparities in survival of patients with breast cancer in sub-Saharan Africa from the African Breast Cancer-Disparities in Outcomes cohort (ABC-DO): a prospective cohort study. Lancet Glob Health. 2024 Jul; 12(7):e1111-e1119.

View in: PubMed
Wang Z, Katsaros D, Wang J, Biglio N, Hernandez BY, Fei P, Lu L, Risch H, Yu H. Machine learning-based cluster analysis of immune cell subtypes and breast cancer survival. Sci Rep. 2023 11 03; 13(1):18962.

View in: PubMed
Wong LL, Landsittel DP, Kwee SA. Liver Transplantation vs Partial Hepatectomy for Stage T2 Multifocal Hepatocellular Carcinoma <3?cm Without Vascular Invasion: A Propensity Score-Matched Survival Analysis. J Am Coll Surg. 2023 09 01; 237(3):568-577.

View in: PubMed
Weir A, Kang EY, Meagher NS, Nelson GS, Ghatage P, Lee CH, Riggan MJ, Gentry-Maharaj A, Ryan A, Singh N, Widschwendter M, Alsop J, Anglesio MS, Beckmann MW, Berger J, Bisinotto C, Boros J, Brand AH, Brenton JD, Brooks-Wilson A, Carney ME, Cunningham JM, Cushing-Haugen KL, Cybulski C, Elishaev E, Erber R, Fereday S, Fischer A, Paz-Ares L, Gayarre J, Gilks BC, Grube M, Harnett PR, Harris HR, Hartmann A, Hein A, Hendley J, Hernandez BY, Heublein S, Huang Y, Huzarski T, Jakubowska A, Jimenez-Linan M, Kennedy CJ, Kommoss FKF, Koziak JM, Kraemer B, Le ND, Lesnock J, Lester J, Lubinski J, Menkiszak J, Ney B, Olawaiye A, Orsulic S, Osorio A, Robles-D?az L, Ruebner M, Shah M, Sharma R, Shvetsov YB, Steed H, Talhouk A, Taylor SE, Traficante N, Vierkant RA, Wang C, Wilkens LR, Winham SJ, Benitez J, Berchuck A, Bowtell DD, Candido Dos Reis FJ, Cook LS, DeFazio A, Doherty JA, Fasching PA, Garc?a MJ, Goode EL, Goodman MT, Gronwald J, Huntsman DG, Karlan BY, Kommoss S, Modugno F, Schildkraut JM, Sinn HP, Staebler A, Kelemen LE, Ford CE, Menon U, Pharoah PDP, K?bel M, Ramus SJ. Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study. Br J Cancer. 2023 01; 128(1):137-147.

View in: PubMed
Modonutti D, Majdalany SE, Corsi N, Li P, Sood A, Dalela D, Jamil ML, Hwang C, Menon M, Rogers CG, Trinh QD, Novara G, Abdollah F. A novel prognostic model predicting overall survival in patients with metastatic castration-resistant prostate cancer receiving standard chemotherapy: A multi-trial cohort analysis. Prostate. 2022 09; 82(13):1293-1303.

View in: PubMed
Sood A, Keeley J, Palma-Zamora I, Novara G, Elshaikh M, Jeong W, Hensley P, Navai N, Peabody JO, Trinh QD, Rogers CG, Menon M, Abdollah F. High-intensity local treatment of clinical node-positive urothelial carcinoma of the bladder alongside systemic chemotherapy improves overall survival. Urol Oncol. 2022 02; 40(2):62.e1-62.e11.

View in: PubMed
Gu S, Lheureux S, Sayad A, Cybulska P, Hogen L, Vyarvelska I, Tu D, Parulekar WR, Nankivell M, Kehoe S, Chi DS, Levine DA, Bernardini MQ, Rosen B, Oza A, Brown M, Neel BG. Computational modeling of ovarian cancer dynamics suggests optimal strategies for therapy and screening. Proc Natl Acad Sci U S A. 2021 06 22; 118(25).

View in: PubMed
Aboulouard S, Wisztorski M, Duhamel M, Saudemont P, Cardon T, Narducci F, Lemaire AS, Kobeissy F, Leblanc E, Fournier I, Salzet M. In-depth proteomics analysis of sentinel lymph nodes from individuals with endometrial cancer. Cell Rep Med. 2021 Jun 15; 2(6):100318.

View in: PubMed
Donlon TA, Chen R, Masaki KH, Willcox DC, Allsopp RC, Willcox BJ, Morris BJ. Association of growth hormone receptor gene variant with longevity in men is due to amelioration of increased mortality risk from hypertension. Aging (Albany NY). 2021 06 01; 13(11):14745-14767.

View in: PubMed
Rivera-Rivera Y, Marina M, Jusino S, Lee M, Vel?zquez JV, Chard?n-Col?n C, Vargas G, Padmanabhan J, Chellappan SP, Saavedra HI. The Nek2 centrosome-mitotic kinase contributes to the mesenchymal state, cell invasion, and migration of triple-negative breast cancer cells. Sci Rep. 2021 04 27; 11(1):9016.

View in: PubMed

People

Explore

Similar Concepts

Top Journals